Detalhe da pesquisa
1.
Tissue Age Affects Antigenicity and Scoring for the 22C3 Immunohistochemistry Companion Diagnostic Test.
Mod Pathol
; 36(7): 100159, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36925070
2.
Multi-Institutional Study of Pathologist Reading of the Programmed Cell Death Ligand-1 Combined Positive Score Immunohistochemistry Assay for Gastric or Gastroesophageal Junction Cancer.
Mod Pathol
; 36(5): 100128, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36889057
3.
Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer.
Lab Invest
; 102(10): 1101-1108, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35595825
4.
A new tool for technical standardization of the Ki67 immunohistochemical assay.
Mod Pathol
; 34(7): 1261-1270, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33536573
5.
Quantitative assessment of PD-L1 as an analyte in immunohistochemistry diagnostic assays using a standardized cell line tissue microarray.
Lab Invest
; 100(1): 4-15, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409885
6.
Targeting c-Met in triple negative breast cancer: preclinical studies using the c-Met inhibitor, Cpd A.
Invest New Drugs
; 38(5): 1365-1372, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32318883
7.
Immune Inhibitory Molecule PD-1 Homolog (VISTA) Colocalizes with CD11b Myeloid Cells in Melanoma and Is Associated with Poor Outcomes.
J Invest Dermatol
; 144(1): 106-115.e4, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37562584
8.
BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome.
Breast Cancer Res
; 15(4): R52, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23820017
9.
Assessment of the Impact of Alternative Fixatives on HER2 Detection in Breast Cancer and Gastric Cancer Tumor Specimens.
Appl Immunohistochem Mol Morphol
; 31(5): 339-345, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37093713
10.
Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer.
PLoS One
; 18(3): e0282512, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920947
11.
Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck Cancer.
Clin Cancer Res
; 28(5): 984-992, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34785584
12.
Bile acid distributions, sex-specificity, and prognosis in colorectal cancer.
Biol Sex Differ
; 13(1): 61, 2022 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36274154
13.
Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes.
Cancer Res
; 81(16): 4346-4359, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34185676
14.
Spatially Resolved and Quantitative Analysis of the Immunological Landscape in Human Meningiomas.
J Neuropathol Exp Neurol
; 80(2): 150-159, 2021 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33393633
15.
PD-L1 Protein Expression on Both Tumor Cells and Macrophages are Associated with Response to Neoadjuvant Durvalumab with Chemotherapy in Triple-negative Breast Cancer.
Clin Cancer Res
; 26(20): 5456-5461, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32709714
16.
Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells.
Cancers (Basel)
; 11(4)2019 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30999598
17.
PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus.
Sci Transl Med
; 11(522)2019 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826980
18.
Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer.
Clin Cancer Res
; 23(2): 370-378, 2017 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27440266
19.
Nuclear IRF-1 expression as a mechanism to assess "Capability" to express PD-L1 and response to PD-1 therapy in metastatic melanoma.
J Immunother Cancer
; 5: 25, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28331615
20.
B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.
Clin Cancer Res
; 23(17): 5202-5209, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28539467